# Effect of Prophylactic Fibrinogen Concentrate In Scoliosis Surgery

> **NCT05391412** · PHASE4 · UNKNOWN · sponsor: **Brno University Hospital** · enrollment: 32 (estimated)

## Conditions studied

- Fibrinogen
- Spine Deformity
- Coagulopathy, Consumption
- Bleeding

## Interventions

- **DRUG:** Fibrinogen Concentrate Human

## Key facts

- **NCT ID:** NCT05391412
- **Lead sponsor:** Brno University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-06-06
- **Primary completion:** 2023-07-30
- **Final completion:** 2023-09-30
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2023-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05391412

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05391412, "Effect of Prophylactic Fibrinogen Concentrate In Scoliosis Surgery". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05391412. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
